Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Wendy Armstrong

Concepts (367)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
65
2024
3022
5.750
 Why?
Epidemics
6
2024
92
2.080
 Why?
Communicable Diseases
8
2023
161
1.890
 Why?
Anti-Retroviral Agents
5
2019
245
1.690
 Why?
Anti-HIV Agents
13
2024
860
1.500
 Why?
Viral Load
13
2023
506
1.140
 Why?
Infectious Disease Medicine
2
2017
12
1.080
 Why?
Continuity of Patient Care
5
2022
287
0.990
 Why?
AIDS-Related Opportunistic Infections
5
2019
128
0.910
 Why?
HIV
13
2023
250
0.900
 Why?
Internal Medicine
3
2016
273
0.900
 Why?
Social Stigma
2
2024
147
0.880
 Why?
Immune Reconstitution Inflammatory Syndrome
2
2019
19
0.760
 Why?
Internship and Residency
6
2021
1240
0.700
 Why?
Pre-Exposure Prophylaxis
3
2024
240
0.690
 Why?
Drug Monitoring
2
2016
399
0.660
 Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
2020
19
0.640
 Why?
Antiretroviral Therapy, Highly Active
6
2019
285
0.640
 Why?
Adenine
2
2020
331
0.630
 Why?
Diagnostic Tests, Routine
2
2021
110
0.620
 Why?
Acquired Immunodeficiency Syndrome
7
2022
235
0.610
 Why?
Humans
94
2024
141754
0.590
 Why?
Consumer Advocacy
1
2018
14
0.580
 Why?
Lost to Follow-Up
2
2017
18
0.560
 Why?
Career Choice
3
2018
233
0.560
 Why?
Health Services Accessibility
4
2024
1027
0.540
 Why?
United States
25
2024
15310
0.540
 Why?
Delivery of Health Care
4
2021
962
0.520
 Why?
Health Policy
3
2023
405
0.510
 Why?
HIV-1
7
2016
895
0.500
 Why?
CD4 Lymphocyte Count
6
2020
284
0.500
 Why?
Substance-Related Disorders
6
2021
1102
0.490
 Why?
Georgia
10
2024
85
0.490
 Why?
Medication Adherence
2
2017
513
0.480
 Why?
Antimicrobial Stewardship
3
2023
119
0.460
 Why?
Disease Management
1
2019
633
0.450
 Why?
HIV-Associated Lipodystrophy Syndrome
1
2014
11
0.440
 Why?
Urban Population
1
2017
485
0.420
 Why?
Biomedical Research
2
2018
708
0.420
 Why?
Financing, Government
1
2014
50
0.420
 Why?
Bone Diseases
1
2014
66
0.420
 Why?
Metabolic Diseases
1
2014
114
0.400
 Why?
Drug Resistance, Viral
2
2005
120
0.390
 Why?
Patient Acceptance of Health Care
2
2017
881
0.390
 Why?
Rural Population
1
2017
606
0.380
 Why?
Ventriculostomy
1
2012
24
0.370
 Why?
Medication Errors
1
2012
97
0.360
 Why?
Chronic Pain
3
2021
280
0.360
 Why?
Central Nervous System Diseases
1
2012
73
0.350
 Why?
Mycoses
1
2012
86
0.350
 Why?
Ambulatory Care
2
2021
587
0.340
 Why?
Prostheses and Implants
1
2012
144
0.330
 Why?
Critical Care
1
2016
650
0.330
 Why?
Disease Transmission, Infectious
1
2011
69
0.330
 Why?
Gram-Positive Bacterial Infections
2
2008
70
0.330
 Why?
Cellulitis
2
2011
55
0.320
 Why?
Microbiology
3
2014
24
0.320
 Why?
Bacterial Infections
1
2012
245
0.310
 Why?
Physicians
5
2019
942
0.310
 Why?
Analgesics, Opioid
5
2021
1123
0.310
 Why?
Dermatitis
1
2008
19
0.300
 Why?
Global Health
2
2018
387
0.290
 Why?
Medical Informatics
1
2009
101
0.290
 Why?
Male
40
2024
70179
0.290
 Why?
Patient-Centered Care
1
2014
550
0.290
 Why?
Female
41
2024
75943
0.290
 Why?
Gram-Negative Bacterial Infections
1
2008
49
0.290
 Why?
Education, Medical, Graduate
5
2023
526
0.280
 Why?
Adult
32
2024
39391
0.280
 Why?
Africa, Eastern
2
2017
11
0.270
 Why?
AIDS Vaccines
2
2005
53
0.270
 Why?
Information Dissemination
1
2009
224
0.270
 Why?
Middle Aged
31
2024
34647
0.260
 Why?
Periodicals as Topic
1
2009
217
0.260
 Why?
Pneumonia, Pneumocystis
4
2015
35
0.250
 Why?
Developing Countries
3
2017
318
0.240
 Why?
Internet
2
2014
690
0.240
 Why?
Mycobacterium chelonae
1
2005
9
0.240
 Why?
Curriculum
5
2023
1039
0.240
 Why?
Databases, Factual
2
2019
1448
0.230
 Why?
Rilpivirine
1
2024
9
0.220
 Why?
Exosomes
2
2016
105
0.210
 Why?
Skin
1
2008
765
0.210
 Why?
Fellowships and Scholarships
4
2023
323
0.210
 Why?
Meningoencephalitis
1
2003
24
0.200
 Why?
Cost-Benefit Analysis
3
2021
619
0.200
 Why?
West Nile virus
1
2003
42
0.200
 Why?
Interviews as Topic
2
2017
854
0.190
 Why?
Pyridones
1
2024
188
0.190
 Why?
Practice Guidelines as Topic
3
2019
1570
0.190
 Why?
Pain Management
3
2021
396
0.180
 Why?
Bacteria
1
2008
881
0.180
 Why?
Anti-Infective Agents
3
2015
239
0.180
 Why?
Simulation Training
1
2023
127
0.180
 Why?
Coronary Artery Bypass
1
2003
243
0.180
 Why?
Colony-Stimulating Factors
1
2001
37
0.170
 Why?
Erythrocyte Transfusion
1
2003
208
0.170
 Why?
Obesity
1
2014
3008
0.170
 Why?
Contact Tracing
1
2020
25
0.170
 Why?
Mycobacterium Infections, Nontuberculous
1
2005
364
0.170
 Why?
Mass Screening
2
2020
1313
0.170
 Why?
Prescription Drug Misuse
1
2021
47
0.170
 Why?
Cities
4
2022
134
0.160
 Why?
Registries
2
2019
2144
0.160
 Why?
Sexual and Gender Minorities
1
2024
234
0.160
 Why?
Erythropoietin
1
2001
98
0.160
 Why?
Models, Theoretical
2
2021
584
0.160
 Why?
Life Expectancy
1
2020
71
0.160
 Why?
Policy
1
2021
149
0.160
 Why?
Interleukin-2
1
2001
456
0.150
 Why?
Health Equity
1
2021
103
0.150
 Why?
Alanine
1
2020
158
0.150
 Why?
Heart Diseases
1
2022
335
0.150
 Why?
Fever of Unknown Origin
1
1999
13
0.150
 Why?
Cross-Sectional Studies
5
2021
5697
0.150
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2019
38
0.150
 Why?
Cohort Studies
7
2019
5815
0.150
 Why?
Mentors
2
2018
212
0.150
 Why?
Prevalence
5
2024
2799
0.140
 Why?
Comorbidity
2
2020
1664
0.140
 Why?
Microbial Sensitivity Tests
3
2016
370
0.140
 Why?
Pandemics
3
2021
1656
0.140
 Why?
Tenofovir
1
2020
285
0.140
 Why?
Sexually Transmitted Diseases
1
2020
167
0.140
 Why?
Physician Assistants
1
2019
97
0.140
 Why?
Patient Identification Systems
1
2017
16
0.130
 Why?
Capital Financing
1
2017
8
0.130
 Why?
Hospitalization
4
2020
2264
0.130
 Why?
Sustained Virologic Response
1
2017
45
0.130
 Why?
Risk Factors
7
2020
10482
0.130
 Why?
Africa
1
2017
119
0.130
 Why?
Anti-Bacterial Agents
4
2011
1866
0.130
 Why?
Nurse Practitioners
1
2019
142
0.130
 Why?
Financing, Personal
1
2016
28
0.120
 Why?
Viral Tropism
1
2016
34
0.120
 Why?
Research Personnel
1
2018
184
0.120
 Why?
Case Management
1
2016
67
0.120
 Why?
Hospitals
2
2021
696
0.120
 Why?
Opioid-Related Disorders
2
2021
564
0.120
 Why?
Motivation
2
2017
603
0.120
 Why?
Pneumonia, Viral
1
2020
374
0.120
 Why?
Coronavirus Infections
1
2020
371
0.110
 Why?
Drug Utilization Review
1
2015
61
0.110
 Why?
Organizational Policy
1
2015
84
0.110
 Why?
HIV Protease Inhibitors
1
2015
68
0.110
 Why?
Time-to-Treatment
1
2017
223
0.110
 Why?
Online Systems
1
2014
21
0.110
 Why?
Esophageal Diseases
1
2015
28
0.110
 Why?
Candidiasis
1
2015
63
0.110
 Why?
Patient Navigation
1
2016
98
0.110
 Why?
Cytosol
1
2015
230
0.110
 Why?
Pregnancy Complications, Infectious
1
2019
408
0.110
 Why?
Alcoholism
1
2021
823
0.110
 Why?
Organophosphates
1
2015
174
0.100
 Why?
Healthcare Disparities
1
2020
673
0.100
 Why?
Ambulatory Care Facilities
1
2016
248
0.100
 Why?
Drug Interactions
1
2015
406
0.100
 Why?
Patient Readmission
1
2019
708
0.100
 Why?
DNA, Viral
2
2012
367
0.100
 Why?
Health Plan Implementation
1
2014
145
0.100
 Why?
Dihydropteroate Synthase
2
2004
3
0.100
 Why?
Telemedicine
1
2021
894
0.090
 Why?
Medication Reconciliation
1
2012
31
0.090
 Why?
Incidence
2
2021
2806
0.090
 Why?
Leukocytes, Mononuclear
1
2015
574
0.090
 Why?
Myocardial Infarction
2
2019
1069
0.090
 Why?
Oligopeptides
1
2014
275
0.090
 Why?
Pilot Projects
2
2017
1826
0.090
 Why?
Aged
8
2022
24746
0.090
 Why?
HIV Antibodies
1
2012
63
0.090
 Why?
Longitudinal Studies
2
2019
2938
0.090
 Why?
Mycobacterium haemophilum
1
2011
1
0.090
 Why?
Socioeconomic Factors
2
2020
1317
0.090
 Why?
Retrospective Studies
7
2022
16374
0.090
 Why?
Primary Health Care
2
2019
1809
0.090
 Why?
Parasitic Diseases
1
2011
8
0.090
 Why?
Cytomegalovirus
1
2012
163
0.090
 Why?
Research
1
2014
455
0.090
 Why?
Pneumocystis
2
2001
8
0.090
 Why?
Catheter-Related Infections
1
2012
92
0.080
 Why?
Mycobacterium Infections
1
2011
62
0.080
 Why?
Electronic Health Records
1
2019
1132
0.080
 Why?
Simian Immunodeficiency Virus
1
2011
92
0.080
 Why?
Simian Acquired Immunodeficiency Syndrome
1
2011
92
0.080
 Why?
Education, Medical, Undergraduate
1
2013
196
0.080
 Why?
Health Care Costs
1
2014
427
0.080
 Why?
Geography
1
2011
201
0.080
 Why?
Cytomegalovirus Infections
1
2012
197
0.080
 Why?
Cytokines
2
2016
2100
0.080
 Why?
Surveys and Questionnaires
5
2023
5974
0.080
 Why?
Sulfonamides
1
2014
567
0.080
 Why?
Pyridines
1
2014
557
0.080
 Why?
Rectum
1
2011
192
0.080
 Why?
Antibodies, Neutralizing
1
2012
323
0.080
 Why?
Adolescent
5
2021
22130
0.080
 Why?
Desiccation
1
2009
22
0.080
 Why?
Deep Brain Stimulation
1
2012
190
0.070
 Why?
Drug Therapy, Combination
3
2014
1041
0.070
 Why?
Colon
1
2011
300
0.070
 Why?
Education, Medical, Continuing
1
2009
133
0.070
 Why?
Emigrants and Immigrants
1
2011
149
0.070
 Why?
Syphilis, Cutaneous
1
2007
3
0.070
 Why?
Immunoglobulin G
1
2012
900
0.070
 Why?
Dendritic Cells
1
2011
505
0.070
 Why?
Specimen Handling
1
2009
182
0.070
 Why?
Hepacivirus
1
2009
238
0.070
 Why?
Plasma
1
2009
221
0.070
 Why?
Risk Assessment
3
2019
3508
0.060
 Why?
B-Lymphocytes
1
2012
859
0.060
 Why?
Treatment Outcome
6
2024
11181
0.060
 Why?
Young Adult
3
2021
13749
0.060
 Why?
Hepatitis C
1
2009
250
0.060
 Why?
HIV-2
1
2005
18
0.060
 Why?
Diagnosis, Differential
2
2007
1502
0.060
 Why?
Dapsone
2
2004
7
0.060
 Why?
CD4-Positive T-Lymphocytes
1
2011
1115
0.060
 Why?
Sex Factors
1
2011
2063
0.060
 Why?
Diketopiperazines
1
2024
21
0.050
 Why?
Patient Education as Topic
1
2009
779
0.050
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2004
42
0.050
 Why?
Pneumocystis carinii
1
2004
11
0.050
 Why?
Chronic Disease
2
2012
1820
0.050
 Why?
Mediastinitis
1
2003
3
0.050
 Why?
Virulence
1
2005
268
0.050
 Why?
Vancomycin Resistance
1
2003
16
0.050
 Why?
Enterococcus faecium
1
2003
21
0.050
 Why?
Delayed-Action Preparations
1
2024
177
0.050
 Why?
Wound Healing
1
2005
350
0.050
 Why?
Fatal Outcome
1
2003
309
0.050
 Why?
Liver Failure
1
2002
80
0.050
 Why?
Biopsy
1
2005
1083
0.050
 Why?
Cryptococcosis
1
2001
31
0.040
 Why?
Transplantation, Homologous
1
2002
415
0.040
 Why?
Dental Care
1
2021
26
0.040
 Why?
Coronary Disease
2
2003
371
0.040
 Why?
Intracranial Hypertension
1
2001
42
0.040
 Why?
Naphthoquinones
1
2001
18
0.040
 Why?
Quality-Adjusted Life Years
1
2021
113
0.040
 Why?
Cytochrome b Group
1
2001
22
0.040
 Why?
Blood
2
2012
113
0.040
 Why?
Adipose Tissue
1
2005
647
0.040
 Why?
Mutation
2
2004
4015
0.040
 Why?
Time Factors
3
2019
6966
0.040
 Why?
Patient Outcome Assessment
1
2021
131
0.040
 Why?
Meningitis
1
2001
81
0.040
 Why?
Renal Insufficiency
1
2002
169
0.040
 Why?
Neutropenia
1
2001
157
0.040
 Why?
Antifungal Agents
1
2001
144
0.040
 Why?
Trust
1
2021
147
0.040
 Why?
Prospective Studies
1
2012
7777
0.040
 Why?
Personal Satisfaction
1
2021
215
0.040
 Why?
Anemia
1
2001
177
0.040
 Why?
JC Virus
1
2019
23
0.040
 Why?
Spinal Diseases
1
1999
51
0.040
 Why?
Polyomavirus Infections
1
2019
30
0.040
 Why?
Boston
1
2019
91
0.040
 Why?
Antiviral Agents
1
2005
747
0.040
 Why?
Asymptomatic Infections
1
2019
36
0.040
 Why?
Esophageal Stenosis
1
1999
56
0.040
 Why?
Abscess
1
1999
77
0.040
 Why?
Polymerase Chain Reaction
3
2011
1056
0.040
 Why?
Insurance, Health
1
2021
299
0.040
 Why?
Training Support
1
2018
37
0.040
 Why?
Benchmarking
1
2019
180
0.040
 Why?
Health Status Disparities
1
2021
298
0.030
 Why?
Preceptorship
1
2018
68
0.030
 Why?
Recombinant Proteins
1
2001
1363
0.030
 Why?
Multicenter Studies as Topic
1
2019
363
0.030
 Why?
Substance Abuse Detection
1
2019
105
0.030
 Why?
Heart-Assist Devices
1
2003
562
0.030
 Why?
Dyslipidemias
1
2019
175
0.030
 Why?
Patient Satisfaction
1
2021
697
0.030
 Why?
Hospitals, Public
1
2017
27
0.030
 Why?
Drug Administration Schedule
1
2019
771
0.030
 Why?
Prenatal Care
1
2019
303
0.030
 Why?
Odds Ratio
1
2019
1057
0.030
 Why?
Medicare
1
2022
808
0.030
 Why?
Needs Assessment
1
2018
385
0.030
 Why?
Postpartum Period
1
2019
354
0.030
 Why?
Ultracentrifugation
1
2016
52
0.030
 Why?
Public Health Surveillance
1
2016
84
0.030
 Why?
Delayed Diagnosis
1
2016
93
0.030
 Why?
Multivariate Analysis
1
2019
1498
0.030
 Why?
Stents
1
1999
531
0.030
 Why?
Virion
1
2016
113
0.030
 Why?
Motivational Interviewing
1
2016
118
0.030
 Why?
Guideline Adherence
1
2019
566
0.030
 Why?
Neopterin
1
2014
13
0.030
 Why?
Darunavir
1
2014
19
0.030
 Why?
Atazanavir Sulfate
1
2014
44
0.030
 Why?
Societies, Medical
1
2018
859
0.030
 Why?
Ritonavir
1
2014
75
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2016
855
0.030
 Why?
Antigens, CD
1
2016
545
0.020
 Why?
Randomized Controlled Trials as Topic
1
2019
1634
0.020
 Why?
Qualitative Research
1
2020
1547
0.020
 Why?
Biomarkers
2
2016
4190
0.020
 Why?
Blood Proteins
1
2014
250
0.020
 Why?
Transplantation
1
2012
33
0.020
 Why?
Inpatients
1
2016
512
0.020
 Why?
Rifabutin
1
2011
6
0.020
 Why?
Clarithromycin
1
2011
23
0.020
 Why?
Ofloxacin
1
2011
17
0.020
 Why?
Smoking
1
2019
1603
0.020
 Why?
Viremia
1
2012
150
0.020
 Why?
Receptors, Immunologic
1
2012
215
0.020
 Why?
Integrins
1
2011
96
0.020
 Why?
Macaca mulatta
1
2011
189
0.020
 Why?
Quality of Life
1
2023
3014
0.020
 Why?
Hypertension
1
2019
1254
0.020
 Why?
Programmed Cell Death 1 Receptor
1
2012
261
0.020
 Why?
RNA, Viral
1
2014
693
0.020
 Why?
Data Interpretation, Statistical
1
2012
377
0.020
 Why?
Practice Patterns, Physicians'
1
2019
1344
0.020
 Why?
Immunocompromised Host
1
2011
203
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
761
0.020
 Why?
Blotting, Western
1
2011
1234
0.020
 Why?
Health Promotion
1
2015
759
0.020
 Why?
Cells, Cultured
1
2016
4212
0.020
 Why?
False Negative Reactions
1
2007
61
0.020
 Why?
Protein Binding
1
2014
2242
0.020
 Why?
Feces
1
2011
505
0.020
 Why?
Neoplasms
1
2002
2747
0.020
 Why?
Flow Cytometry
1
2011
1197
0.020
 Why?
Lymphocyte Activation
1
2011
1150
0.020
 Why?
Cardiovascular Diseases
1
2019
2096
0.020
 Why?
Pregnancy
1
2019
7092
0.010
 Why?
Gene Expression Profiling
1
2011
1771
0.010
 Why?
Genotype
1
2009
1866
0.010
 Why?
Chemoprevention
1
2004
95
0.010
 Why?
T-Lymphocytes
1
2012
2007
0.010
 Why?
China
1
2004
220
0.010
 Why?
Infant
1
2016
9843
0.010
 Why?
Atovaquone
1
2001
3
0.010
 Why?
Child, Preschool
1
2016
11512
0.010
 Why?
Survival
1
2001
39
0.010
 Why?
Ubiquinone
1
2001
35
0.010
 Why?
Reproducibility of Results
1
2009
3356
0.010
 Why?
Gene Amplification
1
2001
103
0.010
 Why?
Cardiomyopathy, Dilated
1
2003
340
0.010
 Why?
Sulfones
1
2000
127
0.010
 Why?
Epidural Space
1
1999
16
0.010
 Why?
Postoperative Complications
2
2003
2821
0.010
 Why?
Animals
2
2011
37749
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
219
0.010
 Why?
Recurrence
1
2001
1111
0.010
 Why?
Radiation Injuries
1
1999
149
0.010
 Why?
Polymorphism, Genetic
1
2001
625
0.010
 Why?
Esophagus
1
1999
259
0.010
 Why?
Heart Transplantation
1
2003
715
0.010
 Why?
Molecular Sequence Data
1
2001
2929
0.010
 Why?
Child
1
2016
22414
0.010
 Why?
Esophageal Neoplasms
1
1999
336
0.010
 Why?
Follow-Up Studies
1
2003
5212
0.010
 Why?
Carcinoma, Squamous Cell
1
1999
645
0.010
 Why?
Case-Control Studies
1
2001
3597
0.010
 Why?
Angina Pectoris
1
1971
64
0.010
 Why?
Coronary Vessels
1
1971
247
0.000
 Why?
Tomography, X-Ray Computed
1
1999
2765
0.000
 Why?
Aorta
1
1971
424
0.000
 Why?
Magnetic Resonance Imaging
1
1999
3737
0.000
 Why?
Angiocardiography
1
1971
1
0.000
 Why?
Methods
1
1971
68
0.000
 Why?
Extracorporeal Circulation
1
1971
15
0.000
 Why?
Saphenous Vein
1
1971
36
0.000
 Why?
Transplantation, Autologous
1
1971
281
0.000
 Why?
Emergencies
1
1971
179
0.000
 Why?
Armstrong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (367) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)